Literature DB >> 8334677

Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity.

A P Launchbury1, N Habboubi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334677     DOI: 10.1016/0305-7372(93)90036-q

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  35 in total

1.  Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma.

Authors:  Agustin Avilés; María J Nambo; Natividad Neri; Sergio Cleto; Claudia Castañeda; Judith Huerta-Guzmàn; Edgar Murillo; Margarita Contreras; Alejandra Talavera; Martha González
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  Anthracyclines: cardiotoxicity and its prevention.

Authors:  J P Hale; I J Lewis
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

3.  Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials.

Authors:  Feng Du; Peng Yuan; Wenjie Zhu; Jiayu Wang; Fei Ma; Ying Fan; Binghe Xu
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

4.  Interaction of Anthracycline 3'-azido-epirubicin with Calf Thymus DNA via Spectral and Molecular Modeling Techniques.

Authors:  Fengling Cui; Xiaoqing Niu; Luyao Li; Pengge Zhang; Guisheng Zhang
Journal:  J Fluoresc       Date:  2015-06-25       Impact factor: 2.217

5.  Antiproliferative activity of liposomal epirubicin on experimental human gliomas in vitro and in vivo after intratumoral/interstitial application.

Authors:  D K Todorov; S S Ninjo; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study.

Authors:  David Strauser; James L Klosky; Tara M Brinkman; Alex W K Wong; Fong Chan; Jennifer Lanctot; Rohit P Ojha; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2014-07-22       Impact factor: 4.442

7.  Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.

Authors:  Kerri A Nottage; Kirsten K Ness; Chenghong Li; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  Br J Haematol       Date:  2014-01-27       Impact factor: 6.998

8.  Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport.

Authors:  Dongmei Ren; Mercè Dalmau; Arlo Randall; Matthew M Shindel; Pierre Baldi; Szu-Wen Wang
Journal:  Adv Funct Mater       Date:  2012-04-23       Impact factor: 18.808

9.  Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.

Authors:  Hoi-Hung Chan; Tian-Huei Chu; Hsin-Fan Chien; Cheuk-Kwan Sun; E-Ming Wang; Huay-Ben Pan; Hsiao-Mei Kuo; Tsung-Hui Hu; Kwok-Hung Lai; Jiin-Tsuey Cheng; Ming-Hong Tai
Journal:  BMC Gastroenterol       Date:  2010-07-22       Impact factor: 3.067

Review 10.  Anthracyclines in the treatment of cancer. An overview.

Authors:  G N Hortobágyi
Journal:  Drugs       Date:  1997       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.